Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George T Grossberg

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
American Journal of Alzheimer'S Disease and Other Dementias|December 7, 2010
Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's diseaseGeorge T Grossberg, Frederick A Schmitt, Xiangyi Meng, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Academic highlights: emerging therapeutic strategies in Alzheimer's diseaseGeorge T Grossberg, Judy Corey-Bloom, Gary W Small, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Prevalence of Parkinson disease and Parkinson disease dementia in community nursing homesMatthew Hoegh, Aalamgeer K Ibrahim, John Chibnall, et al.
Current Psychiatry Reports|May 29, 2013
Caregiver health: health of caregivers of Alzheimer's and other dementia patientsTodd J Richardson, Soo J Lee, Marla Berg-Weger, et al.
The Primary Care Companion for CNS Disorders|February 11, 2015
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementiaCarl H Sadowsky, Joseph L Micca, George T Grossberg, et al.
Expert Opinion on Pharmacotherapy|August 1, 2020
An update on the efficacy and safety of iloperidone as a schizophrenia therapyAjay Nair, Amanie Salem, Anna-Lee Asamoah, et al.
Expert Opinion on Therapeutic Targets|July 21, 2023
The aquaporin-4 water channel and updates on its potential as a drug target for Alzheimer's diseaseBret Silverglate, Xiaoyi Gao, Hannah P Lee, et al.
Journal of the American Medical Directors Association|November 10, 2019
Diagnostic Accuracy of the SLU AMSAD Scale for Depression in Older Adults Without DementiaRita Khoury, Binu Chakkamparambil, John Chibnall, et al.
Journal of the American Medical Directors Association|February 4, 2009
Atypical antipsychotics and the risk of diabetes in an elderly population in long-term care: a retrospective nursing home chart review studyStewart G Albert, George T Grossberg, Papan J Thaipisuttikul, et al.
Expert Opinion on Investigational Drugs|May 28, 2016
Investigational drugs for treating agitation in persons with dementiaRicardo P Garay, Leslie Citrome, George T Grossberg, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
American Journal of Alzheimer'S Disease and Other Dementias|December 7, 2010
Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's diseaseGeorge T Grossberg, Frederick A Schmitt, Xiangyi Meng, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Academic highlights: emerging therapeutic strategies in Alzheimer's diseaseGeorge T Grossberg, Judy Corey-Bloom, Gary W Small, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Prevalence of Parkinson disease and Parkinson disease dementia in community nursing homesMatthew Hoegh, Aalamgeer K Ibrahim, John Chibnall, et al.
Current Psychiatry Reports|May 29, 2013
Caregiver health: health of caregivers of Alzheimer's and other dementia patientsTodd J Richardson, Soo J Lee, Marla Berg-Weger, et al.
The Primary Care Companion for CNS Disorders|February 11, 2015
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementiaCarl H Sadowsky, Joseph L Micca, George T Grossberg, et al.
Expert Opinion on Pharmacotherapy|August 1, 2020
An update on the efficacy and safety of iloperidone as a schizophrenia therapyAjay Nair, Amanie Salem, Anna-Lee Asamoah, et al.
Expert Opinion on Therapeutic Targets|July 21, 2023
The aquaporin-4 water channel and updates on its potential as a drug target for Alzheimer's diseaseBret Silverglate, Xiaoyi Gao, Hannah P Lee, et al.
Journal of the American Medical Directors Association|November 10, 2019
Diagnostic Accuracy of the SLU AMSAD Scale for Depression in Older Adults Without DementiaRita Khoury, Binu Chakkamparambil, John Chibnall, et al.
Journal of the American Medical Directors Association|February 4, 2009
Atypical antipsychotics and the risk of diabetes in an elderly population in long-term care: a retrospective nursing home chart review studyStewart G Albert, George T Grossberg, Papan J Thaipisuttikul, et al.
Expert Opinion on Investigational Drugs|May 28, 2016
Investigational drugs for treating agitation in persons with dementiaRicardo P Garay, Leslie Citrome, George T Grossberg, et al.
Pageof 14